Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julien Labreuche

Showing results (1-10 of 448) with videos related to

Pageof 45
Sort By:
Stroke|March 5, 2011
Bridging therapy in acute ischemic stroke: are we ready for a new standard of care?Mikael Mazighi, Julien Labreuche
The Lancet. Neurology|April 21, 2009
Lipid management in the prevention of stroke: review and updated meta-analysis of statins for stroke preventionPierre Amarenco, Julien Labreuche
Cardiovascular Diabetology. Endocrinology Reports|December 20, 2025
Diabetes, stroke severity and hemodynamic cerebral ischemiaChristian Petitjean, Julien Labreuche
American Journal of Respiratory and Critical Care Medicine|September 21, 2021
Reply to Kasugai <i>et al.</i>: The Mystery of Futility of Appropriate Antibiotics for Coinfection in COVID-19Anahita Rouzé, Julien Labreuche, Saad Nseir
Alimentary Pharmacology & Therapeutics|December 17, 2020
Letter: TIPSS improves muscle mass indices in patients with cirrhosis and severe portal hypertension - authors' replyFlorent Artru, Julien Labreuche, Alexandre Louvet
JAMA|December 20, 2022
Remote Ischemic Conditioning vs Usual Care and Neurologic Function in Acute Moderate Ischemic StrokeFernando Pico, Julien Labreuche, Pierre Amarenco
The Lancet. Neurology|July 22, 2015
Pathophysiology, presentation, prognosis, and management of intracranial arterial dolichoectasiaFernando Pico, Julien Labreuche, Pierre Amarenco
Atherosclerosis|January 19, 2010
Meta-analysis of the effect of nicotinic acid alone or in combination on cardiovascular events and atherosclerosisEric Bruckert, Julien Labreuche, Pierre Amarenco
Alimentary Pharmacology & Therapeutics|December 17, 2020
TIPSS and reversal of sarcopenia, and TIPSS is a promising therapy for sarcopenia in cirrhosis-Authors' replyFlorent Artru, Julien Labreuche, Alexandre Louvet
Lancet (London, England)|September 28, 2010
Lessons from carotid endarterectomy and stenting trialsPierre Amarenco, Julien Labreuche, Mikael Mazighi
Pageof 45

Showing results (1-10 of 448) with videos related to

Sort By:
Pageof 45
Stroke|March 5, 2011
Bridging therapy in acute ischemic stroke: are we ready for a new standard of care?Mikael Mazighi, Julien Labreuche
The Lancet. Neurology|April 21, 2009
Lipid management in the prevention of stroke: review and updated meta-analysis of statins for stroke preventionPierre Amarenco, Julien Labreuche
Cardiovascular Diabetology. Endocrinology Reports|December 20, 2025
Diabetes, stroke severity and hemodynamic cerebral ischemiaChristian Petitjean, Julien Labreuche
American Journal of Respiratory and Critical Care Medicine|September 21, 2021
Reply to Kasugai <i>et al.</i>: The Mystery of Futility of Appropriate Antibiotics for Coinfection in COVID-19Anahita Rouzé, Julien Labreuche, Saad Nseir
Alimentary Pharmacology & Therapeutics|December 17, 2020
Letter: TIPSS improves muscle mass indices in patients with cirrhosis and severe portal hypertension - authors' replyFlorent Artru, Julien Labreuche, Alexandre Louvet
JAMA|December 20, 2022
Remote Ischemic Conditioning vs Usual Care and Neurologic Function in Acute Moderate Ischemic StrokeFernando Pico, Julien Labreuche, Pierre Amarenco
The Lancet. Neurology|July 22, 2015
Pathophysiology, presentation, prognosis, and management of intracranial arterial dolichoectasiaFernando Pico, Julien Labreuche, Pierre Amarenco
Atherosclerosis|January 19, 2010
Meta-analysis of the effect of nicotinic acid alone or in combination on cardiovascular events and atherosclerosisEric Bruckert, Julien Labreuche, Pierre Amarenco
Alimentary Pharmacology & Therapeutics|December 17, 2020
TIPSS and reversal of sarcopenia, and TIPSS is a promising therapy for sarcopenia in cirrhosis-Authors' replyFlorent Artru, Julien Labreuche, Alexandre Louvet
Lancet (London, England)|September 28, 2010
Lessons from carotid endarterectomy and stenting trialsPierre Amarenco, Julien Labreuche, Mikael Mazighi
Pageof 45